Liminatus Pharma's total assets for Q4 2025 were $512.79K, a decrease of -61.80% from the previous quarter. LIMN total liabilities were $10.33M for the fiscal quarter, a 245.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.